Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Teixeira, da, Silva, JA; Bornemann-Cimenti, H; Tsigaris, P.
Optimizing peer review to minimize the risk of retracting COVID-19-related literature.
Med Health Care Philos. 2021; 24(1):21-26
Doi: 10.1007/s11019-020-09990-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Bornemann-Cimenti Helmar
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Retractions of COVID-19 literature in both preprints and the peer-reviewed literature serve as a reminder that there are still challenging issues underlying the integrity of the biomedical literature. The risks to academia become larger when such retractions take place in high-ranking biomedical journals. In some cases, retractions result from unreliable or nonexistent data, an issue that could easily be avoided by having open data policies, but there have also been retractions due to oversight in peer review and editorial verification. As COVID-19 continues to affect academics and societies around the world, failures in peer review might also constitute a public health risk. The effectiveness by which COVID-19 literature is corrected, including through retractions, depends on the stringency of measures in place to detect errors and to correct erroneous literature. It also relies on the stringent implementation of open data policies.
- Find related publications in this database (using NLM MeSH Indexing)
-
COVID-19 - therapy
-
Editorial Policies - administration & dosage
-
Humans - administration & dosage
-
Peer Review - methods
-
Periodicals as Topic - standards
-
Retraction of Publication as Topic - administration & dosage
-
Risk Factors - administration & dosage
-
Time Factors - administration & dosage
- Find related publications in this database (Keywords)
-
Academic quality
-
Correction
-
Public health risk
-
Retraction
-
Type I and II errors
-
Withdrawal